This compound is a synthetic, stereochemically defined molecule featuring a central tetrahydropyran ring substituted with multiple acetate groups, a methylthio group, and a chlorinated biphenyl moiety bearing an ethoxyphenyl substituent. Its structure indicates potential use as a research chemical or synthetic intermediate in medicinal chemistry.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1018899-03-0
(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol tetraacetate
pharmaceutical intermediate
Ammonium bisulfite
Chemical reagent
1H,1H,2H,2H-Perfluorodecyltriethoxysilane
Surface treatment and coating agent for textiles and glass
Hydrazinium hydrazinecarboxylate
Research reagent
N2-tritylolmesartan medoxomil
pharmaceutical intermediate for research and manufacturing
(2S,3S,4R,5S,6R)-2-(3-(4-chlorobenzyl)-4-methylphenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triyl triacetate
pharmaceutical intermediate
Sotagliflozin
pharmaceutical raw material
((2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-(4-chloro-3-((4-hydroxyphenyl)methyl)phenyl)oxan-2-yl)methyl acetate
pharmaceutical intermediate
[(2S,3S,4R,5S,6R)-3,5-diacetyloxy-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyloxan-4-yl] acetate
ABNIXBQXMYTWSJ-UIPNDDLNSA-N
CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)SC)OC(=O)C)OC(=O)C)OC(=O)C)Cl